Year: 2025
Type: article
Abstract: “There are several design elements known to improve stability and longevity of mRNA in cells while also reducing innate immunogenicity...”In the last few years, mRNA has moved to the fore in the vaccine and cell and gene therapy fields, and as a result, its successful production for these downstream applications has never been more crucial. In this podcast episode, Róisín McGuigan, Editor, Nucleic Acid Insights, speaks to Ryan Lahr, Senior R&D Scientist, CELLSCRIPT, about design, production, and quality control of synthesized mRNA for translation in cells.
Source: Nucleic Acid Insights
Author: Ryan Lahr
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: hybrid
OpenAlex ID: W4417330014
FWCI:
Cites:
Cited by:
Related to: